Vega Investment Solutions purchased a new stake in shares of Revvity Inc. (NYSE:RVTY – Free Report) during the 2nd quarter, Holdings Channel reports. The fund purchased 10,492 shares of the company’s stock, valued at approximately $1,167,000.
Other hedge funds have also added to or reduced their stakes in the company. Ascentis Independent Advisors acquired a new position in Revvity in the first quarter valued at approximately $29,000. CYBER HORNET ETFs LLC acquired a new stake in Revvity during the 2nd quarter worth $32,000. MUFG Securities EMEA plc acquired a new stake in Revvity during the 2nd quarter worth $34,000. Global Retirement Partners LLC bought a new stake in shares of Revvity during the 2nd quarter valued at $51,000. Finally, Headlands Technologies LLC bought a new stake in shares of Revvity during the 2nd quarter valued at $49,000. Institutional investors own 86.65% of the company’s stock.
Revvity Price Performance
Shares of RVTY stock opened at $123.08 on Tuesday. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity Inc. has a 12-month low of $81.22 and a 12-month high of $124.97. The firm has a fifty day moving average of $111.90 and a 200-day moving average of $100.48. The firm has a market capitalization of $13.73 billion, a price-to-earnings ratio of 58.61, a price-to-earnings-growth ratio of 2.27 and a beta of 1.07.
Revvity Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio (DPR) is currently 13.33%.
Analyst Ratings Changes
A number of research firms have recently weighed in on RVTY. Stifel Nicolaus cut their price target on Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Evercore reiterated an “outperform” rating on shares of Revvity in a report on Wednesday, August 5th. Sanford C. Bernstein assumed coverage on Revvity in a research note on Friday, June 26th. They issued a “market perform” rating and a $115.00 target price on the stock. TD Cowen restated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Finally, Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 4th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $108.36.
Check Out Our Latest Report on RVTY
About Revvity
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
See Also
- Five stocks we like better than Revvity
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
